01.12.2008 | Research Articles
Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib
Erschienen in: Clinical and Translational Oncology | Ausgabe 12/2008
Einloggen, um Zugang zu erhalten